Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1840
mi
from 91732
Kalamazoo, MI
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1840
mi
from 91732
Kalamazoo, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1840
mi
from 91732
Kalamazoo, MI
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1840
mi
from 91732
Kalamazoo, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1930
mi
from 91732
Saginaw, MI
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1930
mi
from 91732
Saginaw, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1837
mi
from 91732
Wyoming, MI
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1837
mi
from 91732
Wyoming, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1609
mi
from 91732
Jackson, MS
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1341
mi
from 91732
Kansas City, MO
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1351
mi
from 91732
Lee's Summit, MO
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1351
mi
from 91732
Lee's Summit, MO
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1485
mi
from 91732
Mexico, MO
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1485
mi
from 91732
Mexico, MO
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
910
mi
from 91732
Missoula, MT
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
910
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1300
mi
from 91732
Bellevue, NE
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1300
mi
from 91732
Bellevue, NE
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1276
mi
from 91732
Fremont, NE
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1276
mi
from 91732
Fremont, NE
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1300
mi
from 91732
Omaha, NE
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
218
mi
from 91732
Henderson, NV
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
218
mi
from 91732
Henderson, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
387
mi
from 91732
Reno, NV
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
387
mi
from 91732
Reno, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2515
mi
from 91732
Lebanon, NH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2587
mi
from 91732
Newington, NH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2587
mi
from 91732
Newington, NH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2381
mi
from 91732
Haddon Heights, NJ
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2381
mi
from 91732
Haddon Heights, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from 91732
Marlton, NJ
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from 91732
Marlton, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2434
mi
from 91732
Brooklyn, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2434
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2447
mi
from 91732
Great Neck, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2447
mi
from 91732
Great Neck, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2445
mi
from 91732
Hollis, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2445
mi
from 91732
Hollis, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2451
mi
from 91732
Mineola, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2451
mi
from 91732
Mineola, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2435
mi
from 91732
New York, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2433
mi
from 91732
Poughkeepsie, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2245
mi
from 91732
Rochester, NY
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from 91732
Asheboro, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from 91732
Asheboro, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2002
mi
from 91732
Asheville, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2046
mi
from 91732
Boone, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2046
mi
from 91732
Boone, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2210
mi
from 91732
Cary, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2210
mi
from 91732
Cary, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2194
mi
from 91732
Chapel Hill, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2102
mi
from 91732
Charlotte, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2152
mi
from 91732
Greensboro, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2152
mi
from 91732
Greensboro, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2152
mi
from 91732
Greensboro, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2152
mi
from 91732
Greensboro, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2141
mi
from 91732
High Point, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2141
mi
from 91732
High Point, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2282
mi
from 91732
Kinston, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2282
mi
from 91732
Kinston, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2118
mi
from 91732
Salisbury, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2118
mi
from 91732
Salisbury, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2275
mi
from 91732
Wilmington, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2275
mi
from 91732
Wilmington, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1400
mi
from 91732
Fargo, ND
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1400
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1898
mi
from 91732
Centerville, OH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1898
mi
from 91732
Centerville, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials